Closure of US FDA Inspection at Alkem's manufacturing facility located at Indore

The US FDA has issued an Establishment Inspection Report (EIR) for Alkem Laboratories Ltd's manufacturing facility located at Indore which was inspected from 01st July, 2022 to 07th July, 2022.

In response to Form 483 issued by the US FDA containing one observation, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA.

Shares of Alkem Laboratories Limited was last trading in BSE at Rs. 3275.40 as compared to the previous close of Rs. 3255.40. The total number of shares traded during the day was 878 in over 416 trades.

The stock hit an intraday high of Rs. 3289.85 and intraday low of 3245.65. The net turnover during the day was Rs. 2869037.00.

Source : Equity Bulls

Keywords

AlkemLaboratories INE540L01014 Pharmaceuticals EIR USFDA ManufacturingFacility Indore